Caris Life Sciences, Inc. (CAI)

Healthcare · Biotechnology · NASDAQ

Caris Life Sciences, Inc. (CAI) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $6.43B and a free-cash-flow yield of 1.8%. Over the most recent reported fiscal year, revenue grew 97.0%.

Market cap	$6.43B
Trailing P/E	—
FCF yield	1.8%
Revenue growth (YoY)	+97.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live CAI data on Nama Insights →